Characters | Growth positive, N (%) | MDR, N (%) | p value | ESBL producers, N (%) | p value |
---|---|---|---|---|---|
Sex | |||||
 Male (n = 424) | 48 (11.3) | 46 (95.8) | 0.146 | 7 (14.6) | 0.436 |
 Female (n = 346) | 44 (12.7) | 38 (86.4) | 9 (20.5) | ||
Age group | |||||
 < 10 (n = 123) | 12 (9.8) | 12 (100) | 0.77 | 2 (16.7) | 0.596 |
 11–20 (n = 90) | 4 (4.4) | 3 (75) | 0 (0.0) | ||
 21–30 (n = 84) | 9 (10.7) | 8 (88.9) | 1 (11.1) | ||
 31–40 (n = 105) | 21 (20.0) | 20 (95.2) | 5 (23.8) | ||
 41–50 (n = 71) | 8 (11.3) | 7 (87.5) | 3 (37.5) | ||
 51–60 (101) | 11 (10.9) | 10 (90.9) | 2 (18.2) | ||
 > 60 (n = 196) | 27 (13.8) | 24 (88.9) | 3 (11.1) | ||
Department | |||||
 Inpatient (n = 503) | 33 (6.6) | 27 (81.8) | 0.016 | 7 (21.2) | 0.693 |
 Outpatient (n = 197) | 59 (29.9) | 57 (96.6) | 9 (15.3) | ||
Sample | |||||
 Urine (n = 250) | 52 (20.8) | 47 (90.4) | 0.195 | 12 (23.1) | 0.714 |
 Sputum (n = 185) | 18 (9.7) | 18 (100) | 3 (16.7) | ||
 Pus (n = 115) | 6 (5.2) | 4 (66.6) | 0 (0.0) | ||
 Blood (n = 166) | 8 (4.8) | 8 (100) | 1 (12.5) | ||
 Wound (n = 49) | 5 (10.2) | 4 (80) | 0 (0.0) | ||
 Tissue (n = 5) | 3 (60.0) | 2 (66.6) | 0 (0.0) | ||
n = 770 | n = 92 (11.9) | n = 84 (91.3) | Â | n = 16 (17.4) | Â |